Moderate

Hypertensive nephrosclerosis

HTN nephrosclerosis · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Chronic kidney damage from long-standing hypertension causing arteriolar and glomerular sclerosis, presenting as slowly progressive CKD with modest proteinuria and a bland sediment. Management centres on blood-pressure control and cardiovascular risk reduction.

Red flags

  • Rapidly declining eGFR (suggests alternative diagnosis)
  • Heavy/nephrotic-range proteinuria
  • Active urinary sediment (casts, dysmorphic cells)
  • Malignant hypertension with end-organ damage
  • Asymmetric kidneys or renovascular features

Assessment

Differential diagnosis

  • Hypertensive nephrosclerosis
  • Diabetic kidney disease
  • Primary glomerular disease (FSGS)
  • Renovascular/ischaemic nephropathy
  • Chronic tubulointerstitial disease
  • APOL1-associated nephropathy

Investigations

  • Blood pressure (clinic and out-of-office)
  • eGFR trend and urine ACR (usually modest proteinuria)
  • Urinalysis (bland sediment, no active casts)
  • Renal ultrasound (symmetrically small, smooth kidneys in advanced disease)
  • Exclude other causes (glucose, immunology where indicated)
  • Assessment for end-organ damage (ECG/echo, retinal exam)

Management

  • Establish the diagnosis clinically: long-standing hypertension, slowly progressive CKD, modest proteinuria and a bland urinary sediment
  • Exclude mimics (diabetes, glomerulonephritis, renovascular disease) when the picture is atypical or proteinuria is heavy
  • Set and achieve a blood-pressure target (generally <130/80, individualised)
  • Use an ACE inhibitor or ARB first-line, especially with albuminuria
  • Add calcium-channel blocker and/or diuretic (loop if eGFR <30) to reach target
  • Reinforce lifestyle: sodium restriction, weight management, exercise, smoking cessation, alcohol moderation
  • Consider an SGLT2 inhibitor for albuminuric CKD to slow progression
  • Aggressively manage cardiovascular risk (statin, antiplatelet where indicated)
  • Avoid nephrotoxins (NSAIDs) and review medications
  • Monitor eGFR, ACR, potassium and BP regularly
  • Investigate any acceleration in decline or new heavy proteinuria for an alternative diagnosis
  • Refer to nephrology for rapid progression, diagnostic doubt or advanced CKD

Drugs & doses

Ramipril 2.5-10 mg PO daily OR losartan 50-100 mg PO daily
Amlodipine 5-10 mg PO once daily
Indapamide 2.5 mg PO daily (eGFR >30) or furosemide 20-80 mg PO daily (eGFR <30)
Dapagliflozin 10 mg PO once daily (albuminuric CKD)
Atorvastatin 20 mg PO once daily

Disposition

Primary care/CKD clinic with BP optimisation. Nephrology referral for rapid decline, heavy proteinuria or diagnostic uncertainty.

Complications & pitfalls

  • Progressive CKD and end-stage kidney disease
  • Cardiovascular events and left ventricular hypertrophy
  • Hyperkalaemia from RAAS therapy
  • Accelerated/malignant hypertension
  • Retinopathy

Exam pearls

  • It is a diagnosis of exclusion — heavy proteinuria or active sediment should prompt a search for another cause
  • Bland sediment and modest proteinuria are typical
  • BP control is the key intervention to slow progression
  • Consider APOL1-associated nephropathy in patients of West African ancestry with apparent hypertensive CKD
  • Small smooth symmetrical kidneys support chronicity

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.